Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2015
Pulmonary Embolism and Infarct After Bilateral Cochlear Implantation in a Patient with Newly Diagnosed Sickle/β+ Thalassemia.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang Shan, Nickel Christopher, Lalwani Anil K
Аннотация
OBJECTIVE: To heighten awareness of increased postoperative thromboembolic complications in patients with β-hemoglobinopathies.
PATIENT: A 42-year-old African American woman with previously undiagnosed β-hemoglobinopathies suffers from sensorineural hearing loss caused by bacterial meningitis and undergoes bilateral cochlear implantation.
INTERVENTION(S): Diagnostic: hemoglobin electrophoresis. Therapeutic: cochlear implantation, anticoagulation.
MAIN OUTCOME MEASURE(S): Risk of thromboembolic event.
RESULTS: Five days after surgery, the patient developed pulmonary embolism and infarct in the right lower lobe, which was treated with a 4-month course of anticoagulation. Hemoglobin electrophoresis showed that the patient had a previously undiagnosed rare β-hemoglobinopathy known as sickle/β+ thalassemia.
CONCLUSION: β-Hemoglobinopathies are associated with a higher incidence of thromboembolism; thus, they should be managed aggressively to prevent or treat perioperative thrombosis.
PATIENT: A 42-year-old African American woman with previously undiagnosed β-hemoglobinopathies suffers from sensorineural hearing loss caused by bacterial meningitis and undergoes bilateral cochlear implantation.
INTERVENTION(S): Diagnostic: hemoglobin electrophoresis. Therapeutic: cochlear implantation, anticoagulation.
MAIN OUTCOME MEASURE(S): Risk of thromboembolic event.
RESULTS: Five days after surgery, the patient developed pulmonary embolism and infarct in the right lower lobe, which was treated with a 4-month course of anticoagulation. Hemoglobin electrophoresis showed that the patient had a previously undiagnosed rare β-hemoglobinopathy known as sickle/β+ thalassemia.
CONCLUSION: β-Hemoglobinopathies are associated with a higher incidence of thromboembolism; thus, they should be managed aggressively to prevent or treat perioperative thrombosis.